Castle Biosciences Inc
CSTL
Get informed when a big investor buys or sells
+ FollowMarket Cap$719.43M
Close$
$33.86
46.4% upside
Current Fair Value
46.4% upsideUndervalued by 46.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $719.43 Million |
|---|---|
| Enterprise Value | $692.39 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.83 |
| Beta | 1 |
| Outstanding Shares | 29,889,000 |
Return
| Return on Equity | -2.78% |
|---|---|
| Return on Assets | -2.34% |
| Return on Invested Capital | -6.33% |
Valuation & Multiples
| P/E Ratio | -55.23 |
|---|---|
| PEG | 126.04 |
| Price to Sales | 2.1 |
| Price to Book Ratio | 1.54 |
| Enterprise Value to Revenue | 2.04 |
| Enterprise Value to EBIT | -21.93 |
| Enterprise Value to Net Income | -54 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-0.49
Average shareholder expectationRevenue Estimate
$79.28 M
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$-0.44
Average shareholder expectationRevenue Estimate
$86.24 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 19.35% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.00%▼ 93.13% |
|---|---|
| Total Invested | $7.11M▼ 98.95% |
| Investors Holding | 4▼ 186.00% |
ESG Score
No data